56
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2015891
Desyncra™ CR® Neuromodulation is an innovative medical technology for the treatment of neurological conditions
About the Company
Desyncra™ is a medical technology company for the treatment of brain-related conditions. Our award-winning Coordinated Reset (CR®) Neuromodulation technology was developed by Professor Peter Tass at the Jülich Research Centre, and can be used for the treatment of: tinnitus, Parkinson's disease, epilepsy, and migraine. Our T30 device for
tinnitus has FDA approval and the CE mark and is currently available in the UK, Germany, Netherlands and Switzerland.
